26 December 2024 in Irish Journal of Psychological Medicine
Background: Cannabis is the most commonly used illicit substance in Ireland and globally. It is most likely to be used in adolescence, a period of biopsychosocial vulnerability to maladaptive behaviours. This study aims to investigate the risk and protective factors for cannabis use among adolescents.Methods: This study is a secondary analysis of the cross-sectional Planet Youth survey (2021). The sample comprised 4,404 adolescents aged 15–16 from one urban and two rural areas in Ireland. The outcome of interest was current cannabis use, defined as cannabis use within the last 30 days. Independent variables i.e., risk and protective factors, were selected a priori following a literature review. Associations between cannabis use and the independent variables were explored using mixed-effects logistic regressions.Results: The prevalence of current cannabis use was 7.3% and did not differ significantly between males and females. In fully-adjusted models, significant risk factors for cannabis use were: Having peers that used cannabis (Adjusted Odds Ration (aOR) 10.17, 95% CI: 5.96–17.35); Parental ambivalence towards cannabis use (aOR 3.69, 95% CI: 2.41–5.66); Perception of cannabis as non-harmful (aOR 2.32,95% CI 1.56–£.45): Other substance use (aORs ranging from 2-67–3.15); Peer pressure to use cannabis (aOR 1.85,95% CI 1.05–3.26), and Low parental supervision (aOR 1.11, 95% CI: 1.01–1.22).Conclusions: This study identified key individual, peer-to-peer and parental risk factors associated with adolescent cannabis use, several of which have the potential to be modified through drug prevention strategies.
26 May 2026 in Irish Journal of Psychological Medicine
Background: Substances, such as cannabis, alcohol, and nicotine, have each been associated with an increased risk of mental health concerns in adolescence. These substances are often taken concurrently and less is known about the effects of polysubstance use. We investigated the relationship between polysubstance use and psychopathology in adolescence including internalising, externalising behaviours, and psychotic experiences (PE). As a secondary analysis, we examined gender differences. Methods: A sample of 4,404 15–16-year-old adolescents in 40 schools in Ireland was examined. Our exposure was single substance use (cannabis, alcohol, and nicotine) and polysubstance use within the past month. The outcome of interest was psychopathology, measured using the Strengths & Difficulties Questionnaire, and the Adolescent Psychotic Symptoms Scale. Associations were explored using mixed-effects logistic models. Results: Adjusted odds ratios were calculated to examine the associations between polysubstance use and each outcome, compared to substance-naive participants. A significant dose response relationship was observed, with increasing substance use associated with higher odds of general psychopathology (aOR range: 1.65–5.09), internalising behaviours (aOR range: 1.18–2.06), externalising behaviours (aOR range: 1.68–5.79), and PE (aOR range: 1.60–3.13). Females engaging in polysubstance use exhibited the poorest mental health outcomes. Conclusion: This study highlights the strong associations between adolescent polysubstance use and emerging mental health problems. The findings reinforce the need for mental health services to take polysubstance use into consideration during intervention. Tailored public health messaging is required, acknowledging polysubstance use as a marker for poor mental health among adolescents and young adults.
14 September 2026 in Psychiatry Research: Neuroimaging
7 January 2024 in Open Access Government
Risk factors for cannabis use in young people: With cannabis use among young people on the rise, Ronan Fleury, Prof Bobby Smyth and Prof Mary Cannon. discuss the mental and physical impacts and the importance of understanding the risk factors. Cannabis remains the most widely used illegal drug among teenagers. Research indicates that usage typically begins between ages 12 and 17, with this age group making up about two-thirds of new users. (14) According to the European Monitoring Centre for Drugs and Drug Addiction, approximately 23 million people in Europe (8% of those aged 15-64 years) had used cannabis in 2022. (8) Among European 16-year-olds, daily cannabis use has slightly increased from about 0.5% in 1995 to 0.8% in 2019. (9) In the United States, the increase is more striking, with daily use among 16-year-olds rising from 0.8% in 1991 to 4.8% in 2019. (11)
14 May 2026 in Psychological Medicine
Polysubstance use is increasingly the norm among adolescents who use substances, yet research and clinical frameworks remain concentrated in single-substance models. This narrative conceptual editorial highlights key emerging literature on the conceptual inconsistencies and methodological challenges in polysubstance use research, particularly in the context of shifting cannabis legislation and adolescent vulnerability. A lack of definitional consensus, regarding the number of substances, timing of engagement, and intent of substances used, undermines the comparability of findings and the effectiveness of interventions. Adolescent polysubstance use is shaped by developmental, social, and structural factors, with cannabis and nicotine frequently overlooked despite their prevalence. This editorial addresses three linked gaps: definitional inconsistencies, insufficient attention to timing and intent of co-use, and the continued dominance of single-substance research frameworks. Therefore, we argue for clearer definitions, inclusive research designs, and interdisciplinary approaches.
10 January 2024 in Open Access Government
Empowering voices: Breaking mental health stigma: John Hoey and Mary Cannon from Department of Psychiatry, RCSI University of Medicine and Health Sciences, Dublin, Ireland, share their research around breaking mental health stigma to empower voices. Research consistently shows that people from marginalised groups are almost four times as likely to experience mental conditions such as psychotic symptoms than the majority population (van der Ven et al., 2022). Yet, they are much less likely to seek timely clinical intervention or reach out to friends and family for support. Why is this, and what can be done to encourage people to seek help? In our April 2024 blog “Can the Arts be an Effective Tool to Combat Psychosis Stigma,” we described stigma, as defined in the Oxford English Dictionary, as “Negative feelings that people have about particular circumstances or characteristics that somebody may have.” Although in recent years, attitudes towards certain mental conditions such as anxiety or depression have become more ‘normalised’ and openly discussed, other conditions, such as psychotic symptoms, remain stubbornly stigmatic and shrouded in fear. When it comes to mental health, those who both fear most, and are the subjects of fear, are marginalised groups, which can negatively impact both engagement and recovery.